Synopsis of recent research by authors named "Yingshi Zhang"
- Yingshi Zhang's recent research primarily focuses on the therapeutic effects of various pharmacological agents in treating different forms of cancer, including colorectal cancer, hepatocellular carcinoma, and the implications of PI3K/AKT inhibitors.
- Their studies employ systematic reviews and meta-analyses to evaluate the efficacy and safety of novel treatments such as HDAC inhibitors, glucagon-like peptide-1 receptor agonists, and anti-TNF-α monoclonal therapies, emphasizing personalized approaches in medicine.
- Zhang's work also explores the predictive capabilities of machine learning in oncology, aiming to enhance early detection of cancers such as intrahepatic cholangiocarcinoma and optimize treatment strategies based on patient-specific factors like neutrophil/lymphocyte ratios.
